Search

everythinglearnresearchcommunity

for

Search:↓

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Adults should not consume more than 255 micrograms of selenium per day to avoid risk of hair loss and other side effects.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Herbal extracts may help hair grow and could be an alternative to synthetic hair loss treatments.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Monilethrix is a genetic hair disorder causing fragile, beaded hair with no effective treatment.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

PCOS has a strong genetic basis, but more research is needed to fully understand it.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

PCOS is a complex condition that affects women's hormonal balance and metabolism, requiring lifestyle changes and medical management.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

Zinc is essential for plant growth and human health, but many soils lack enough zinc, affecting crops and potentially leading to health problems.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

Finasteride, a drug used for certain conditions, can cause serious side effects like sexual dysfunction, suicidal thoughts, and increased diabetes risk, and there's a need for more awareness and research about these effects.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Finasteride doesn't harm bone density in older men with BPH.

Honokiol might help reduce male skin aging by maintaining testosterone levels.